Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-16 Sale | 2024-01-17 5:31 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 39,384 | $0.70064 | $27,594 | 44,848 (Direct) | View |
| 2024-01-11 Sale | 2024-01-12 5:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 29,202 | $0.84698 | $24,734 | 26,388 (Direct) | View |
| 2023-09-01 Sale | 2023-09-01 7:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 2,403 | $0.78 | $1,874 | 3,449 (Direct) | View |
| 2023-06-27 Sale | 2023-06-27 9:15 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 2,333 | $0.92 | $2,146 | 3,519 (Direct) | View |
| 2023-01-17 Sale | 2023-01-17 9:15 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 10,057 | $1.858 | $18,686 | 13,351 (Direct) | View |
| 2023-01-11 Sale | 2023-01-12 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 31,805 | $1.7227 | $54,791 | 24,882 (Direct) | View |
| 2023-01-04 Sale | 2023-01-04 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 5,073 | $1.694 | $8,594 | 6,631 (Direct) | View |
| 2022-09-01 Sale | 2022-09-01 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 2,536 | $1.9689 | $4,993 | 3,316 (Direct) | View |
| 2022-06-27 Sale | 2022-06-27 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 2,562 | $1.63 | $4,176 | 3,290 (Direct) | View |
| 2022-01-18 Sale | 2022-01-18 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 11,096 | $3.1918 | $35,416 | 12,312 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 17,408 | $3.5545 | $61,877 | 3,356 (Direct) | View |
| 2022-01-04 Sale | 2022-01-05 9:04 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 5,532 | $4.0642 | $22,483 | 6,172 (Direct) | View |
| 2021-09-01 Sale | 2021-09-01 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 2,782 | $5.195 | $14,452 | 3,070 (Direct) | View |
| 2021-06-28 Sale | 2021-06-28 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 2,794 | $4.37 | $12,210 | 3,058 (Direct) | View |
| 2021-01-19 Sale | 2021-01-19 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 9,879 | $5.6695 | $56,009 | 13,529 (Direct) | View |
| 2021-01-12 Sale | 2021-01-12 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 2,707 | $6.1522 | $16,654 | 3,695 (Direct) | View |
| 2021-01-04 Sale | 2021-01-05 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 4,967 | $5.3279 | $26,464 | 6,737 (Direct) | View |
| 2020-09-01 Sale | 2020-09-02 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 2,776 | $8.5149 | $23,637 | 3,076 (Direct) | View |
| 2020-08-03 Sale | 2020-08-04 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 2,788 | $9.25 | $25,789 | 3,064 (Direct) | View |
| 2020-01-14 Sale | 2020-01-15 8:01 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 3,236 | $5.1347 | $16,616 | 3,166 (Direct) | View |
| 2020-01-06 Sale | 2020-01-07 8:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 5,900 | $1.2 | $7,080 | 5,804 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-12 Option Award | 2024-08-14 6:00 pm | N/A 2029-08-12 | Wave Life Sciences Ltd. | WVE | Rawcliffe Adrian Director | 48,345 | $0 | 48,345 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:00 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 9,329,568 | $0 | 9,329,568 (Direct) | View |
| 2023-08-07 Option Award | 2023-08-09 8:00 pm | N/A 2028-08-07 | Wave Life Sciences Ltd. | WVE | Rawcliffe Adrian Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 9:01 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 6,488,496 | $0 | 6,488,496 (Direct) | View |
| 2022-08-15 Option Award | 2022-08-17 8:01 pm | N/A 2027-08-15 | Wave Life Sciences Ltd. | WVE | Rawcliffe Adrian Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-13 9:00 pm | N/A 2032-01-12 | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 5,737,704 | $0 | 5,737,704 (Direct) | View |
| 2021-08-16 Option Award | 2021-08-18 6:10 pm | N/A 2026-08-16 | Wave Life Sciences Ltd. | WVE | Rawcliffe Adrian Director | 42,000 | $0 | 42,000 (Direct) | View |
| 2021-01-11 Option Award | 2021-01-11 9:02 pm | N/A 2031-01-11 | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 3,988,560 | $0 | 3,988,560 (Direct) | View |
| 2020-08-18 Option Award | 2020-08-20 6:32 pm | N/A 2025-08-18 | Wave Life Sciences Ltd. | WVE | Rawcliffe Adrian Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2020-01-16 Option Award | 2020-01-17 9:30 pm | N/A 2030-01-16 | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 3,077,328 | $0 | 3,077,328 (Direct) | View |